XML 26 R15.htm IDEA: XBRL DOCUMENT v3.21.2
Long-term Debt
9 Months Ended
Sep. 30, 2021
Debt Disclosure [Abstract]  
Long-term Debt Long-term Debt
September 30, 2021December 31, 2020
 (In millions)
Term loan, bearing interest at variable rates (rate of 1.83% as of September 30, 2021), maturing in September 2023
$288.8 $308.5 
Unamortized deferred financing costs(0.9)(1.4)
Total senior debt287.9 307.1 
Convertible senior notes, bearing interest at 2.25% per annum, interest payments due in June and December, maturing in December 2023
145.9 300.0 
Unamortized discount and deferred financing costs(10.5)(28.4)
Total convertible senior notes135.4 271.6 
Finance leases43.9 45.6 
Total other debt43.9 45.6 
Total debt, net of unamortized discount and deferred financing costs467.2 624.3 
Less: Amounts due within one year(163.6)(299.9)
Total long-term debt, net of unamortized discount and deferred financing costs$303.6 $324.4 
Senior Credit Facility
The senior secured senior credit facility (the "Senior Credit Facility") matures on September 20, 2023, and consists of (i) a $650.0 million revolving line of credit (the "Revolver") and (ii) a $350.0 million term loan (the "Term Loan").
As of September 30, 2021, the Company had zero borrowings under the Revolver and issued $27.6 million in letters of credit.
The Term Loan and any borrowings under the Revolver bear interest at LIBOR plus an applicable margin ranging from 175 to 250 basis points based on the Company's leverage ratio (the "Consolidated Net Leverage Ratio") measured at the end of each quarter. In addition to interest, the Company must pay certain fees including (i) letter of credit fees ranging from 175 to 250 basis points per annum on the amount of issued but undrawn letters of credit and eurocurrency rate loans and (ii) commitment fees ranging from 30 to 45 basis points per annum on the unused portion of the Revolver. 
The Term Loan amortized at a rate of 7.5% per annum as of December 31, 2020, and increasing to 10.0% per annum from December 31, 2022, to be paid in equal quarterly installments with any remaining amounts, along with outstanding borrowings under the Revolver, due on the maturity date. Outstanding borrowings under the Revolver and the Term Loan may be voluntarily repaid at any time, in whole or in part, without premium or penalty.
The Senior Credit Facility is secured by a first priority security interest in the Company’s assets, subject to certain customary exceptions, as well as pledges of its equity interests in certain subsidiaries.
The Senior Credit Facility contains financial covenants requiring the Company to (i) maintain an interest coverage ratio (the "Consolidated Interest Coverage Ratio") of not less than 3.00 to 1.00 and (ii) maintain a Consolidated Net Leverage Ratio not to exceed (a) 3.75 to 1.00 from October 1, 2020, through September 30, 2021; and (b) 3.50 to 1.00 from October 1, 2021, thereafter, provided that the maximum leverage ratio for all periods shall be increased by 0.50 to 1.00 for two consecutive quarters after consummation of a qualified acquisition. 
The Company may generally make certain investments, redeem debt subordinated to the Senior Credit Facility and make certain restricted payments (such as stock repurchases and dividends) if the Company's Consolidated Net Leverage Ratio does not exceed 3.25 to 1.00 pro forma for such transaction. The Company is otherwise subject to customary covenants including limitations on asset sales, incurrence of additional debt, and limitations on certain investments and restricted payments.
The Company was in compliance with its financial and non-financial covenants as of September 30, 2021.
2¼% Convertible Senior Notes
On December 14, 2016, the Company issued $300.0 million aggregate principal amount of 2¼% Notes in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.
In the nine months ended September 30, 2021, the Company settled $154.1 million of its 2¼% Notes. The principal amount was settled in cash and the conversion premium was settled in common shares. See Note 11.
Holders may convert their 2¼% Notes at their option from October 1, 2021, through December 31, 2021, because the Company's closing stock price exceeded $33.80 for at least 20 days in the 30 day period prior to September 30, 2021. The Company has a stated intention to cash settle the principal amount of the 2¼% Notes with the conversion premium to be settled in common shares. Accordingly, the net balance of the 2¼% Notes of $135.4 million is classified as a current liability as of September 30, 2021.
As more fully described in the indenture governing the 2¼% Notes, the holders of the 2¼% Notes may surrender all or any portion of their 2¼% Notes for conversion at any time during any calendar quarter, (and only during such calendar quarter), if the last reported sale price of the Company's common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% ($33.80) of the conversion price on each applicable trading day.
The following table summarizes information regarding the 2¼% Notes (in millions, except years, percentages, conversion rate, and conversion price):
September 30, 2021December 31, 2020
Carrying amount of equity component, net of equity issuance costs$— $54.5 
Remaining amortization period (years)2.253.0
Effective interest rate 5.8 %5.8 %
Conversion rate (shares of common stock per $1,000 principal amount)38.461538.4615
Conversion price (per share of common stock)$26.00 $26.00 
Based on the Company's closing stock price of $43.55 on September 30, 2021, the if-converted value of the 2¼% Notes exceeded the aggregate principal amount of the 2¼% Notes by $98.5 million.
The following table presents the interest expense components for the 2¼% Notes:
Three months ended September 30,Nine months ended September 30,
 2021202020212020
 (In millions)
Interest expense-contractual interest$0.8 $1.7 $2.4 $5.1 
Interest expense-amortization of debt discount1.0 2.0 3.2 5.9 
Interest expense-amortization of deferred financing costs0.1 0.2 0.3 0.5